NewEdge Advisors’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14
| Closed | -$64 | – | 3982 |
|
|
2024
Q1 | $64 | Sell |
14
-1
| -7% | -$5 | ﹤0.01% | 3718 |
|
|
2023
Q4 | $100 | Hold |
15
| – | – | ﹤0.01% | 3640 |
|
|
2023
Q3 | $91 | Hold |
15
| – | – | ﹤0.01% | 3369 |
|
|
2023
Q2 | $120 | Hold |
15
| – | – | ﹤0.01% | 3414 |
|
|
2023
Q1 | $64 | Hold |
15
| – | – | ﹤0.01% | 3351 |
|
|
2022
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 4186 |
|